Recursion Pharmaceuticals Inc share price logo

Recursion Pharmaceuticals Inc

NASDAQ: RXRX

Small Cap

$3.31

-0.10

(-3.08%)

as on

Recursion Pharmaceuticals Inc Stock Performance

as on April 30, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.20
    $3.38
    downward going graph

    3.32%

    Downside

    2.11%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.80
    $7.18
    downward going graph

    15.41%

    Downside

    116.92%

    Upside

    downward going graph

Recursion Pharmaceuticals Inc share price movements today

Previous Close
$3.41
Open
$3.38
Volume
14.9M
Day's Low - High
$3.20 - $3.38
52 Week Low - High
$2.80 - $7.18

Recursion Pharmaceuticals Inc Historical Returns

1 Month Return
+ 15.99 %
3 Month Return
-21.06 %
1 Year Return
-40.38 %
3 Year Return
-28.51 %
5 Year Return
0 %

Recursion Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Recursion Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-0.948

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-564.4M

Revenue (TTM)

74.7M

Profit Margin

0.00%

Return On Equity TTM

-59.54%

Recursion Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Recursion Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.8BNANA0.00%
BUY$40.3B116.27%129.668.45%
BUY$108.4B103.03%27.7732.94%
NA$33.1BNA120.715.37%
BUY$78.0B50.88%17.9531.41%

Stock Returns calculator for Recursion Pharmaceuticals Inc Stock including INR - Dollar returns

The Recursion Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Recursion Pharmaceuticals Inc investment value today

Current value as on today

₹64,435

Returns

-₹35,565

(-35.56%)

Returns from Recursion Pharmaceuticals Inc Stock

-₹42,133 (-42.13%)

Dollar Impact

₹6,568 (+6.57%)

Analyst Recommendation on Recursion Pharmaceuticals Inc Stock

Based on 13 analysts

BUY

53.85%

Buy

46.15%

Hold

0.00%

Sell

Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Recursion Pharmaceuticals Inc. Average target price of $6.71

Recursion Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Recursion Pharmaceuticals Inc.

What analysts predicted

50.67%UPSIDE

Target Price

$6.71

Current Price

$3.31

Analyzed by

13 Analysts

Target

$6.71

Recursion Pharmaceuticals Inc target price $6.71, a slight upside of 50.67% compared to current price of $3.31. According to 13 analysts rating.

Recursion Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Investment in Recursion Pharmaceuticals Inc Shares on INDmoney has dropped by -17.54% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-17.54% versus previous 30 day period

Search interest for Recursion Pharmaceuticals Inc Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:10% versus previous 30 day period

Recursion Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
10
10
13
14
26
4
14
19
5
35
Gross Profit
0
0
2
5
14
-8
-7
-1
-24
8
Operating Income
-99
-98
-96
-100
-98
-183
-191
-176
-172
-108
EBITDA
-85
-89
-84
-88
-87
-165
-182
-147
-141
-88
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
7
7
7
8
7
12
19
23
21
19
Income Before Tax
-93
-97
-92
-98
-95
-178
-202
-171
-162
-108
Income Tax Expense
1
-4
0
0
0
0
0
-
0
0
Net Income
-93
-92
-91
-97
-95
-178
-202
-171
-162
-108
Net Profit Margin
-920.78%
-875.34%
-677.29%
-677.17%
-366.82%
-3965.99%
-1373.26%
-899.84%
-3135.32%
-304.25%

Recursion Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
3
10
39
43
58
74
Gross Profit
-44
3
10
-8
1
13
-46
Operating Income
-62
-84
-182
-245
-350
-479
-648
EBITDA
-58
-81
-174
-233
-307
-426
-559
Interest Expense
0
1
2
0
0
1
1
Depreciation
3
4
8
11
20
36
83
Income Before Tax
-61
-87
-186
-239
-332
-464
-644
Income Tax Expense
0
0
-8
0
-4
-1
0
Net Income
-62
-87
-178
-239
-328
-463
-644
Net Profit Margin
-3654.30%
-2549.25%
-1780.74%
-603.36%
-747.71%
-788.02%
-863.35%

Recursion Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-92
-91
-97
-95
-178
-202
-171
-162
-108
Operating Cash Flow
-74
-102
-82
-59
-115
-131
-76
-117
-46
Investing Cash Flow
-2
-6
-4
-4
275
-7
-5
-2
-1
Financing Cash Flow
80
13
263
16
10
40
97
251
132
Change in Cash
4
-95
176
-46
167
-93
24
133
86

Recursion Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-87
-186
-239
-328
-463
-644
Operating Cash Flow
-45
-158
-83
-287
-359
-371
Investing Cash Flow
-8
-271
193
-10
260
-16
Financing Cash Flow
246
458
154
140
304
521
Change in Cash
191
28
263
-157
201
150

Global Institutional Holdings in Recursion Pharmaceuticals Inc

Funds
Holdings
Novo A/S
2.21%
MIC Capital Management UK LLP
1.83%
Susquehanna International Group, LLP
0.83%
DCVC Opportunity Fund II GP, LLC
0.75%
ARK Investment Management LLC
6.35%

Recursion Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 23 February

    Mon, 05:41 PM

    -

    Nvidia exits its investment in Recursion while ARK Invest increases its stake; Recursion secures $30 million milestone payment.

    Mon, 06:30 PM

    -

    Recursion to be featured in NVIDIA GTC Lightning Talk, showcasing advancements in AI-driven drug discovery.

Insights on Recursion Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 5.17M → 35.53M (in $), with an average increase of 85.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -202.48M → -108.12M (in $), with an average increase of 24.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 28.6% return, outperforming this stock by 69.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, RECURSION PHARMACEUTICALS-A has experienced a drawdown of -28.5%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 19.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, RXRX stock has moved down by -8.6%

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia. The company has collaboration and agreement with Roche & Genentech; Sanofi; Bayer AG; Tempus; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
OrganisationRecursion Pharmaceuticals Inc
Headquarters41 South Rio Grande Street, Salt Lake City, UT, United States, 84101
IndustryBiotechnology
CEODr. Najat Khan Ph.D.
E-voting on sharesClick here to vote

Key Management of Recursion Pharmaceuticals Inc

Name

Title

Mr. Ben R. Taylor

CFO & President of Recursion UK

Dr. David J. Mauro M.D., Ph.D.

Advisor

Ms. Kristen Rushton M.B.A.

Chief Operating Officer

Mr. Ryan Kelly

Chief Communications Officer

Ms. Erica Fox

Chief People and Impact Officer

Dr. Najat Khan Ph.D.

CEO, President & Director

Mr. Benjamin Mabey M.S.

Chief Technology Officer

Dr. David Hallett Ph.D.

Chief Scientific Officer

Mr. Nathan Hatfield J.D., M.B.A.

Chief Legal Officer & Corporate Secretary

Dr. Christopher C. Gibson Ph.D.

Co-Founder, Chairman & Interim Executive Advisor

FAQs

What is Recursion Pharmaceuticals Inc share price today?

Recursion Pharmaceuticals Inc share price today is $3.31 as on at the close of the market. Recursion Pharmaceuticals Inc share today touched a day high of $3.38 and a low of $3.2.

What is the 52 week high and 52 week low for Recursion Pharmaceuticals Inc share?

Recursion Pharmaceuticals Inc share touched a 52 week high of $7.18 on and a 52 week low of $2.8 on . Recursion Pharmaceuticals Inc stock price today i.e. is closed at $3.31,which is 53.90% down from its 52 week high and 18.21% up from its 52 week low.

What is Recursion Pharmaceuticals Inc's market capitalisation today?

Recursion Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Recursion Pharmaceuticals Inc Stock (RXRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Recursion Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Recursion Pharmaceuticals Inc Shares that will get you 0.4532 shares as per Recursion Pharmaceuticals Inc share price of $3.31 per share as on April 30, 2026 at 1:29 am IST.

What is the minimum amount required to buy Recursion Pharmaceuticals Inc Stock (RXRX) from India?

Indian investors can start investing in Recursion Pharmaceuticals Inc (RXRX) shares with as little as ₹94.82 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹948.20 in Recursion Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Recursion Pharmaceuticals Inc share’s latest price of $3.31 as on April 30, 2026 at 1:29 am IST, you will get 3.0211 shares of Recursion Pharmaceuticals Inc. Learn more about fractional shares .